ArticleExperimental hematology & oncology2025

Dickkopf-1 promotes tumor progression of gefitinib- resistant non-small cell lung cancer through cancer cell-fibroblast interactions.

Munkyung Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.